Wells Fargo & Company Acer Therapeutics Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.57 - $1.28 $0 - $1	1 Added 0.76%	133 $0
Q2 2023 Aug 15, 2023	BUY	$0.75 - $1.14 $40 - $61	54 Added 69.23%	132 $0
Q1 2023 May 12, 2023	BUY	$0.67 - $3.05 $2 - $9	3 Added 4.0%	78 $0
Q4 2022 Feb 13, 2023	BUY	$1.13 - $4.15 $5 - $20	5 Added 7.14%	75 $0
Q3 2022 Nov 14, 2022	BUY	$1.28 - $1.6 $2 - $3	2 Added 2.94%	70 $0
Q2 2022 Aug 12, 2022	BUY	$1.19 - $3.04 $11 - $30	10 Added 17.24%	68 $0
Q3 2021 Nov 15, 2021	BUY	$2.3 - $2.86 $32 - $40	14 Added 31.82%	58 $0
Q2 2021 Aug 16, 2021	SELL	$2.52 - $3.18 $2 - $3	-1 Reduced 2.22%	44 $0
Q1 2021 May 13, 2021	BUY	$2.47 - $4.39 $39 - $70	16 Added 55.17%	45 $0
Q3 2020 Nov 05, 2020	SELL	$2.16 - $5.41 $185 - $465	-86 Reduced 74.78%	29 $0
Q2 2020 Aug 13, 2020	SELL	$1.53 - $4.53 $15,902 - $47,084	-10,394 Reduced 98.91%	115 $0
Q1 2020 May 14, 2020	BUY	$1.18 - $5.86 $12,400 - $61,582	10,509 New	10,509 $21,000

365

Ticker ACER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,100,000
Description
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mu...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.